Paclitaxel Injection for nandispersion (PICN)
Anticancer PICN, (Paclitaxel Injection Concentrate for Nanodispersion) the flagship product from SPARC, is the most exciting of all projects at SPARC. PICN is in trials in the US and has already been launched in India.
First, a note on the technology. Water insoluble anticancers have two issues with their use, first, toxic surfactants often have to be used to solubilise the drug; and secondly, such drugs not only reach the tumor tissues but also reach and penetrate healthy tissues in the body.
Our novel self dispersing Nanotecton platform addresses these challenges with higher drug localization to the cancer cells, lesser excipient, and a higher dose
Products made with our technology do not need any pre-administration preparation, such as the administration of antihistamines or steroids, or the use of in-line filters.
Now we move on to PICN.